Drug or treatment

Alectinib clinical trials

• 8Clinical trials
• 31Countries

Newest trials

All recruiting trials (8)

• Alectinib plus duvelisib for ALK-positive anaplastic large cell lymphoma

  This trial tests whether combining alectinib with duvelisib is a safe, time-limited treatment for people with relapsed or refractory ALK-positive anaplastic large cell lymphoma.

  Recruiting at 7 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07001384

• Evaluating outcomes of ALK-positive lung cancer patients treated with Alectinib after surgery

  This study is testing if Alectinib can help adults with ALK-positive lung cancer feel better after their surgery.

  Recruiting at 43 sites Hoffmann-La Roche · Zhanjiang, Guangdong and 43 other locations · NCT06862869

• Treatment for advanced ALK-positive non-small cell lung cancer

  This study is testing whether a new drug called neladalkib can help people with advanced ALK-positive non-small cell lung cancer live longer without their disease getting worse compared to the standard treatment, alectinib.

  Recruiting at 158 sites Phase 3 Nuvalent Inc. · Glendale, Arizona and 158 other locations · NCT06765109

• Alectinib treatment for ALK-positive cancers in adults and children

  This study is testing if alectinib, a drug for lung cancer, can help treat different types of ALK-positive cancers in both adults and children.

  Recruiting at 24 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT05770037

• Combining Alectinib with Radiation Therapy for Advanced Lung Cancer with ALK Mutation

  This study is testing if combining alectinib with targeted radiation therapy can help people with advanced lung cancer that has an ALK mutation feel better and live longer.

  Recruiting Karolinska University Hospital · Stockholm · NCT05724004

• Evaluating alectinib in patients with advanced lung cancer

  This study is testing how well alectinib works and how the body processes it in Mexican patients with advanced lung cancer that has a specific genetic change.

  Recruiting Phase 1/2 Instituto Nacional de Cancerologia de Mexico · Mexico City, Mexico City · NCT05713006

• Comparing standard and adjusted doses of alectinib for lung cancer treatment

  This study is testing if adjusting the dose of alectinib based on blood levels can help people with ALK positive lung cancer live longer without their disease getting worse compared to the standard dose.

  Recruiting at 7 sites Phase 4 University Medical Center Groningen · Villejuif, Val-de-Marne and 7 other locations · NCT05525338

• Combining Pembrolizumab, Bevacizumab, and Chemotherapy for Advanced Lung Cancer with ALK Mutation

  This study is testing a new combination of two drugs and chemotherapy to see if it helps people with advanced lung cancer that has an ALK mutation and hasn't improved with another treatment.

  Recruiting Phase 2 Hunan Province Tumor Hospital · Changsha, Hunan · NCT05266846

Quick answers

How many clinical trials of Alectinib are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 31 countries. The most sites are in United Kingdom (2 trials), China (2 trials), United States (2 trials), France (2 trials), Mexico (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 1: 1, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →